538 filings
8-K
RSLS
ReShape Lifesciences Inc.
10 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:57pm
8-K
RSLS
ReShape Lifesciences Inc.
9 Apr 24
Changes in Registrant's Certifying Accountant
7:32pm
8-K
RSLS
ReShape Lifesciences Inc.
4 Apr 24
Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX
11:12am
10-K
2023 FY
RSLS
ReShape Lifesciences Inc.
Annual report
1 Apr 24
5:18pm
8-K
RSLS
ReShape Lifesciences Inc.
26 Feb 24
Submission of Matters to a Vote of Security Holders
4:19pm
DEF 14A
RSLS
ReShape Lifesciences Inc.
Definitive proxy
24 Jan 24
12:00am
8-K
RSLS
ReShape Lifesciences Inc.
18 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:38pm
SC 13G
RSLS
ReShape Lifesciences Inc.
17 Jan 24
ReShape Lifesciences / Schneid Yair ownership change
12:00am
3
Yair Schneid
16 Jan 24
ReShape Lifesciences / Yair Schneid ownership change
6:11pm
PRE 14A
RSLS
ReShape Lifesciences Inc.
Preliminary proxy
5 Jan 24
4:14pm
8-K
RSLS
ReShape Lifesciences Inc.
29 Nov 23
Entry into a Material Definitive Agreement
4:05pm
10-Q
2023 Q3
RSLS
ReShape Lifesciences Inc.
Quarterly report
8 Nov 23
6:19pm
8-K
RSLS
ReShape Lifesciences Inc.
8 Nov 23
Third Quarter Core Operating Expenses Reduced 37% Compared to Third Quarter of 2022
5:44pm
4
Thomas Stankovich
8 Nov 23
ReShape Lifesciences / THOMAS STANKOVICH ownership change
4:16pm
8-K
RSLS
ReShape Lifesciences Inc.
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:42pm
8-K
RSLS
ReShape Lifesciences Inc.
5 Oct 23
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
4:05pm
424B4
RSLS
ReShape Lifesciences Inc.
3 Oct 23
Prospectus supplement with pricing info
9:23am
EFFECT
RSLS
ReShape Lifesciences Inc.
2 Oct 23
Notice of effectiveness
12:15am
CORRESP
RSLS
ReShape Lifesciences Inc.
28 Sep 23
Correspondence with SEC
12:00am
S-1/A
RSLS
ReShape Lifesciences Inc.
IPO registration (amended)
27 Sep 23
5:30pm